Mercy BioAnalytics

Waltham, MA · Founded 2018 · Privately Held (backing)

Developer of a novel liquid biopsy assay platform designed to relieve suffering and save lives through the early detection of cancer. Mercy BioAnalytics is based in Waltham, MA and was founded in 2018. It was valued at $122 million at its later-stage round in Mar 2023, the last priced event on record. It has raised $127 million across 1 recorded round; the latest was a $27.3 million early-stage round in Nov 2020.

PMV mark · valuation
$122.0M
Oct 2026
Priced at
its later-stage round
Mar 2023
Total raised
$127.3M
Last round
Early Stage VC
Nov 2020
How much has Mercy BioAnalytics raised?
$127.3Macross 1 recorded rounds · Nov 2020 – Nov 2020

Most recently, Mercy BioAnalytics raised $27.3M in its Early Stage VC (Nov 2020).

Free account
More of Mercy BioAnalytics with a free account
  • ·The complete investor list: 25 names
  • ·Watch Mercy BioAnalytics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Mercy BioAnalytics round by round

1 rounds
Nov 2020Early Stage VC$27.3MSEC filing▮
57 investors participated

How much has Mercy BioAnalytics raised?

Mercy BioAnalytics has raised $127 million in total; 1 of its rounds is on record. The largest on record was a $27.3 million early-stage round in Nov 2020.

Mercy BioAnalytics has filed 1 Form D with the SEC, most recently in Feb 2021 ($27.3 million sold to 57 investors).

Mercy BioAnalytics investors

25 investors are on record for Mercy BioAnalytics, including New Enterprise Associates, Jump Capital, Labcorp Venture Fund and Hatteras Venture Partners. By type, the record holds 9 venture capital firms and 1 hedge fund. The early-stage round in Nov 2020 drew 57 investors.

For fundraisers
Raising for a company like Mercy BioAnalytics?

25 investors have backed Mercy BioAnalytics.

See all 25 investors →

Frequently asked about Mercy BioAnalytics

How much has Mercy BioAnalytics raised?
Mercy BioAnalytics has raised $127.3M in total across 1 recorded funding rounds.
When was Mercy BioAnalytics's last funding round?
Mercy BioAnalytics's most recent recorded round was Early Stage VC in Nov 2020, raising $27.3M.